08:00 , Jan 10, 2011 |  BC Week In Review  |  Company News

AvtivBiotics Pharma, TrioBiotics Pharma AG deal

The companies mutually terminated TrioBiotics' proposed acquisition of ActivBiotics. ActivBiotics said the termination was due to TrioBiotics' failure to raise €5 million ($6.6 million) to fund development of ActivBiotics' antibiotic rifalazil. In July, TrioBiotics...